Thoratec moves up cardiac ranking with $570 million buy
This article was originally published in Clinica
Executive Summary
Thoratec Laboratories is to buy Thermo CardioSystems - a rival cardiac assist company more than three times its size - in a stock-swap transaction valued at some $570 million.